PCDHGA12 inhibitors constitute a distinct class of chemical compounds designed to selectively modulate the activity of the protocadherin gamma subfamily A member 12 (PCDHGA12) protein. Protocadherins, a subset of cell adhesion molecules, play pivotal roles in various physiological processes, particularly in the nervous system, where they contribute to neuronal development and the establishment of synaptic connections. PCDHGA12, belonging to the gamma subfamily, is specifically expressed in neural tissues, where it participates in intricate molecular interactions governing the formation and maintenance of neural circuits. The inhibitors developed for PCDHGA12 target the protein's unique structural features, engaging specific binding sites to interfere with its normal functioning at the molecular level.
The chemical structure of PCDHGA12 inhibitors is carefully crafted to ensure high specificity, preventing unintended interactions with closely related protocadherins. By disrupting the normal cellular activities associated with PCDHGA12, these inhibitors offer a tool for researchers to elucidate the precise molecular mechanisms underlying neural development and synaptic plasticity. The intricate interplay between PCDHGA12 and other cellular components underscores the significance of this chemical class in advancing our understanding of the fundamental processes governing neural circuit formation. As researchers delve deeper into the molecular intricacies of PCDHGA12 inhibition, this class of compounds may provide valuable insights into the broader landscape of cell adhesion and signaling pathways, with potential applications in elucidating neural development processes and related fields of scientific inquiry.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may inhibit DNA methyltransferases, potentially leading to hypomethylation and altered gene expression of PCDHGA12. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, decitabine may lead to DNA demethylation and potentially suppress PCDHGA12 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, an HDAC inhibitor, might change the chromatin structure around the PCDHGA12 gene, potentially decreasing its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A can inhibit histone deacetylase, possibly leading to altered chromatin and lower PCDHGA12 expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 could prevent DNA methylation, potentially reducing expression of genes like PCDHGA12. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can modulate the epigenetic landscape, potentially leading to changes in gene expression, including PCDHGA12. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds GC-rich sequences in DNA, potentially affecting the transcription of genes such as PCDHGA12. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is known to inhibit HDAC, which could potentially result in altered PCDHGA12 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as an HDAC inhibitor, may induce histone hyperacetylation and affect PCDHGA12 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can alter DNA replication and transcription, potentially affecting PCDHGA12 gene expression. | ||||||